Wolfspeed Securities Class Action (WOLF)

WOLFSPEED (NYSE: WOLF) – Maizner v. Wolfspeed, Inc., No. 6:25-cv-46 (Jan. 8, 2025, N.D.N.Y.) – Securities class action filed on behalf of investors that purchased or otherwise acquired Wolfspeed securities between August 16, 2023 and November 6, 2024, both dates inclusive (the “Class Period”). Learn more about this case by clicking Wolfspeed complaint.

If you own WOLF stock and have questions about potential legal claims, please email us at [email protected] or complete our Securities Class Action Questionnaire. All submissions are confidential, evaluations of potential legal claims are free, and there is no obligation to take further action.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Target Corporation Shareholder Derivative Lawsuit (TG)

TARGET CORPORATION (NYSE: TG) – McCollum v. Cornell, et al., 2:25-cv-00021 (Jan. 9, 2025, M.D. Fla.) – Verified shareholder derivative complaint filed against certain current and former board members and executive officers seeking to remedy alleged breaches of fiduciary duties and violations of federal law. Learn more about this case by clicking Target Corporation complaint.

If you own TG stock and have questions about potential legal claims, please email us at [email protected] or complete our Securities Class Action Questionnaire. All submissions are confidential, evaluations of potential legal claims are free, and there is no obligation to take further action.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Five9, Inc. Class Action Lawsuit (FIVN)

FIVE9, INC. (NASDAQ: FIVN)  Lucid Alternative Fund, LP v. Five9, Inc., et al., 3:24-cv-08725 (Dec. 4, 2024, N.D. Cal.) – Securities class action on behalf of all persons and entities that purchased or acquired Five9 securities, including call options, between June 4, 2024 through the close of trading on August 8, 2024, inclusive (the “Class Period”). Learn more about this case by clicking FIVE9 complaint.

If you own FIVN stock and have questions about potential legal claims, please email us at [email protected] or complete our Securities Class Action Questionnaire. All submissions are confidential, evaluations of potential legal claims are free, and there is no obligation to take further action.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Driven Brands Class Action Lawsuit (DRVN)

DRIVEN BRANDS (NASDAQ: DRVN)  Terwilliger v. Fitzpatrick, et al., No. 3:25-vs-00019 (Jan. 10, 2024, W.D.N.C.) – Verified shareholder derivative complaint filed against certain officers and directors of Driven Brands Holdings Inc. alleging breaches of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement, and waste of corporate assets. Learn more about this case by clicking Driven Brands complaint.

If you own DRVN stock and have questions about potential legal claims, please email us at [email protected] or complete our Securities Class Action Questionnaire.

All submissions are confidential, evaluations of potential legal claims are free, and there is no obligation to take further action.

SEND US A MESSAGE

Contact Us

ADDRESS

Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

TransMedics Group Securities Investigation (TMDX)

Kehoe Law Firm, P.C. is investigating potential securities class action claims on behalf of investors of TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX) stock after the Company’s stock price dropped significantly during intraday trading today.

INVESTORS OF TRANSMEDICS STOCK WITH FINANCIAL LOSSES MAY HAVE LEGAL OPTIONS AND ARE ENCOURAGED TO CONTACT KEHOE LAW FIRM, P.C. FOR A FREE EVALUATION OF POTENTIAL SECURITIES CLAIMS RELATED TO TMDX’S STOCK DROP.

The Company’s stock decline follows the release of a critical report by Scorpion Capital, accusing TransMedics of unethical business practices, including extortion, racketeering, and organ trafficking under the guise of a medical device company.

Key Allegations in the Scorpion Capital Report:

  • “Mafia-style” extortion, racketeering, and organ trafficking schemes
  • Kickbacks and billing fraud
  • Unreported device failures and off-label misuse of the Organ Care System

INVESTORS OF TRANSMEDICS STOCK WITH FINANCIAL LOSSES INTERESTED IN LEARNING MORE ABOUT THE CLASS ACTION INVESTIGATION ALSO CAN CLICK HERE, EMAIL [email protected], OR CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected].